CoViPa

CoViPa: Virological and immunological determinants of COVID-19 pathogenesis - lessons to get prepared for future pandemics The ongoing COVID-19 pandemic caused by SARS-CoV-2 has major global impact on human society, economy and daily life. The virus emerged as zoonotic transmission and since the end of 2019 spread around the globe. To gain knowledge about the virological and immunological drivers of COVID-19 pathogenesis and the parameters of immune protection, the interdisciplinary network COVIPA pursues two major goals: 1. Determine the virological and immunological parameters underlying COVID-19 pathogenesis in order to define targeted therapies and to inform vaccine development; 2. To use SARS-CoV-2 as paradigm to gather knowledge and establish durable technology platforms for studying spillover risks and disease mechanisms shared by other pathogens of pandemic potential. The long-term goal is to exploit these mechanisms for broad-spectrum therapeutic approaches and novel technologies applicable for infectious diseases in general. Further information: www.dkfz.de/en/covipa/covipa.html